![Hans Lennernäs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans Lennernäs
Fondateur chez
Canthera AB
Profil
Hans Lennernäs was the founder of DuoCort Pharma AB, founded in 2007, and LIDDS AB, founded in 2003, where the title held was Director & Head-Preclinical Development.
Dr. Lennernäs is also the founder of Empros Pharma AB,Canthera AB..
Dr. Lennernäs currently holds the position of Director at Recipharm Pharmaceutical Development AB and Director at Dr. Lennernäs Biomedical AB. Former positions include Independent Director at Nanologica AB and Professor at the University of Uppsala.
Education includes a doctorate degree from the University of Uppsala.
Postes actifs de Hans Lennernäs
| Sociétés | Poste | Début |
|---|---|---|
Recipharm Pharmaceutical Development AB
 Recipharm Pharmaceutical Development AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Hans Lennernäs Biomedical AB
 Hans Lennernäs Biomedical AB Miscellaneous Commercial ServicesCommercial Services Provides medical research, development and teaching of own and manage real estate | Directeur/Membre du Conseil | - |
Canthera AB
 Canthera AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceuticals and medical equipment | Fondateur | - |
Anciens postes connus de Hans Lennernäs
| Sociétés | Poste | Fin |
|---|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
DuoCort Pharma AB
 DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for glucocorticoid therapy | Fondateur | - |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of overweight and obesity | Fondateur | - |
| NANOLOGICA AB | Directeur/Membre du Conseil | - |
| LIDDS AB | Fondateur | - |
Formation de Hans Lennernäs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
DuoCort Pharma AB
DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for glucocorticoid therapy | Health Technology |
Recipharm Pharmaceutical Development AB
Recipharm Pharmaceutical Development AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of overweight and obesity | Health Technology |
Hans Lennernäs Biomedical AB
Hans Lennernäs Biomedical AB Miscellaneous Commercial ServicesCommercial Services Provides medical research, development and teaching of own and manage real estate | Commercial Services |
Nanologica AB
 Nanologica AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Health Technology |
Canthera AB
Canthera AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceuticals and medical equipment | Health Technology |
